Home Cart Sign in  
Chemical Structure| 2274819-46-2 Chemical Structure| 2274819-46-2

Structure of LUT014
CAS No.: 2274819-46-2

Chemical Structure| 2274819-46-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

LUT-014 is a B-Raf inhibitor with an IC50 of 11.7 nM, and it is developed to reduce dose-limiting acneiform lesions associated EGFR inhibitors treatment.

Synonyms: LUT014

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of LUT014

CAS No. :2274819-46-2
Formula : C27H19F3N8O
M.W : 528.49
SMILES Code : FC(F)(F)OC1=CC=CC(NC2=NC=CC3=C2C=CC(C)=C3NC4=C(C5=C6NC=NC6=NC=N5)C=CC=N4)=C1
Synonyms :
LUT014
MDL No. :MFCD32062738
InChI Key :FZPYULHBUBXPIG-UHFFFAOYSA-N
Pubchem ID :138319775

Safety of LUT014

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of LUT014

MAPK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03876106 EGFR Inhibitor Induced Acneifo... More >>rm Lesions Less << PHASE1 COMPLETED 2020-11-18 UCLA Health Santa Monica - Can... More >>cer Care, Los Angeles, California, 90404, United States|Washington University School of Medicine-Dermatology, Saint Louis, Missouri, 63110, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10022, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Rabin Medical Center, Petach Tikva, 4941492, Israel|Sheba Medical Center, Ramat Gan, 5266202, Israel Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.89mL

0.38mL

0.19mL

9.46mL

1.89mL

0.95mL

18.92mL

3.78mL

1.89mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories